Dr. Anthony Reder is an expert on multiple sclerosis (MS) and an instrumental faculty member in the University of Chicago Medicine's large MS program. He managed a clinical trial site for Ocrevus (ocrelizumab), a breakthrough treatment for MS recently approved by the FDA.